|
Real-time Estimate
Cboe BZX
19:11:49 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 24.86 USD | +0.34% |
|
-5.88% | -13.98% |
| 08-25 | Oruka Therapeutics Names Chief Commercial Officer | MT |
| 08-20 | Arcutis Biotherapeutics' Zoryve Gets Health Canada Approval for Children With Atopic Dermatitis | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ARQT Stock
- Consensus Arcutis Biotherapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
